Category: Best Stocks Right Now

In this section of the Traders-Paradise’s website, our experts estimate what Best Stocks Right Now investors and traders can buy. It doesn’t matter if someone is interested to trade or invest in them. An opportunity is an event, that can comes once and disappear, or last for a long time. Traders-Paradise gives the readers a hint on both.

Best Stocks Right Now aims to spotlight trading and investing opportunities that might be beneficial and profitable.
For traders and investors, providing investing ideas is extremely important. In the section Best Stocks Right Now, readers are not getting ideas only. All posts are full reviews on suggested investment opportunities, sometimes explained trough writing on particular asset classes but mostly they are comprehensive reviews on companies.

Why Best Stocks Right Now?

By adding this section, our aim wasn’t to give advice. Our aim is to give you an idea of where to invest right now, what are the hottest investments in particular periods of time. Also, we point some asset classes that could be the best investment choice for particular periods depending on events, news, and market conditions primarily.

Also, we suggest to our readers the best investing or trading strategy for a particular stock or asset class. The visitors can read fully explained strategies in the section Best Stocks Right Now based on technical and fundamental analysis.
We hope you’ll here find an investment that suits you best.

  • Axsome Therapeutics (AXSM) Is A Good Investment

    Axsome Therapeutics (AXSM) Is A Good Investment

    Axsome Therapeutics (AXSM) Is A Good InvestmentAxsome Therapeutics gained 1.70% in the last trading day ( Friday, Nov 29), increasing from $38.71 to $ 39.37. Will the company be able to continue growing?

    By Guy Avtalyon

    Axsome Therapeutics is developing innovative therapies for the treatment of CNS disorders. Yes, clinical-stage biotech stocks can be a risky suggestion for investors. Well, at the same time this stock is extremely suitable for any dynamic investors. If you prefer an aggressive approach to your investment this stock deserves your attention.

    Axsome Therapeutics (AXSM) has jumped over 1.200% in this year. The investors are awaiting the biotech’s upcoming clinical study results excited. Well, the company is in a late-stage study for its AXS-05. It is innovative and important in treating a depressive disorder, so-called MDD to the end of the year. The company is awaiting results from another study, a drug for treating treatment-resistant depression and it will be published to the end of the first quarter in 2020. Also, Axsome Therapeutics expects to present excellent results from a study of AXS-05 for Alzheimer’s disease in the first six months of 2020. 

    To the end of this year, the company is expected to present the results from a late-stage study of AXS-07 in treating migraine and of AXS-12 in treating narcolepsy. Analysts estimate AXS-05 could obtain annual sales of more than $1 billion when approved. 

    The main problem is that Axsome Therapeutics’ results could be failed like it is with so many drugs.
    But if they get a good result this stock will be high rocketed. 

    The current price is $39.37 (Nov 29). This small-cap stock in the S&P 500 had the greatest total return over the past 12 months. It is 959.6%

     

    Why invest in Axsome Therapeutics

    Axsome Therapeutics, Inc can be a profitable investment option for investors wanting good returns. Axsome Therapeutics, Inc quote is $39.370 on December 2. This stock can provide more than 300% of revenue after 5 years since it is expected the price to rise to $160 in the next year.

    Axsome Therapeutics has a median target of $46.50, where a high estimate of $53.00 and a low estimate of $25.00. The median estimate represents a +18.11% jump from the current price. The investment analysts’ suggestion is to buy this stock. 

    Axsome Therapeutics ABOUT

    The company’s market cap is $1.36B. Axsome Therapeutics reported Q3 2019 financial results on Nov 7, 2019.

    Axsome Therapeutics is a clinical-stage biopharmaceutical company that develops innovative treatments for CNS disorders, especially for those with limited treatment possibilities. Axsome’s center CNS product portfolio covers four clinical-stage products, AXS-05, AXS-07, AXS-09, and AXS-12. AXS-05 is in a phase 3 test in treatment-resistant depression, the same as MDD, and a Phase 2/3 trial in difficulties connected with Alzheimer’s disease. AXS-05 is also being developed for smoking end therapy. AXS-07 is in two Phase 3 trials for the treatment of migraine. AXS-12 is in a Phase 2 trial in narcolepsy.

    AXS-05, AXS-07, AXS-09, and AXS-12 are drug products not approved by the FDA. For more specific information, you have to visit the company’s website. The Company may occasionally disseminate material, nonpublic information on the company website.

    Is AXSM a good investment?

    This company’s liquidity data is interesting: its Quick Ratio is 1.41 and its Current Ratio is 1.41. This shows a good ratio between its short-term liquid assets and its short-term liabilities. So we can easily conclude it is a less risky investment. This stock’s RSI score is at 50.78, which means that the stock is not oversold or overbought.
    The important clinical wins could place this company on the route to produce greater gains. Hence, we think it is a good investment.

     

  • Target Corporation The Hot Stock In The Market

    Target Corporation The Hot Stock In The Market

    Target Corporation The Hot Stock In The Market
    Target Corporation’s market capitalization is $64.11B with the total outstanding Shares of 179.
    The company has an EPS growth of 8.06% for the coming year.

    By Guy Avtalyon

    Target Corporation (NYSE: TGT) has made excellent moves in the late years. They developed a lot of benefits to customers. Besides remodeling their stores, they added same-day fulfillments, in-store orders for goods, and delivery through Shipt and Drive Up. The result was that the TGT stock price rose almost twice in 2019.

    The best of all, the holidays are coming and it looks that Target is prepared for an extra rise in sales. Target Corporation has added 50 million paid hours and has increased the number of employees, all of this with the expectation that the sales will grow over the holidays. To make a better offer to customers, the company added 10.000 new toys, including Disney’s products and numerous cheap gifts that you have to pay less than $15. Moreover, they made a deal with Toys R Us to improve online sales. 

    So, Target looks prepared for Black Friday and holiday shopping season.

    TGT price was $126.89 yesterday (Nov 26) and marked an increase of 1.36% or $1.70.

    Investors were fascinated with Target Corporation

    Target has almost doubled its market value this year. Its quarterly reports fascinated investors. Over a third-quarter, Target rose its comparable sales by 4.5%. That drives the stock price to the sky.

    The company’s digital comparable sales increased by 31% in Q3. The great contribution came from Its same-day fulfillment services. That should provide a Target to have strong traffic in the fourth quarter.

    It is possible for Target’s earnings to go up to 10%.  

    If you want to trade TGT stock Traders Paradise tool shows that you can set up stop-loss at  -2% and take-profit level at +1.75%, which will give you a nice return of $74,78 in less than two days on your investment of $10.000. But it is better if you check it on your by your own.

     

    The future of  TGT stock

    We at Traders-Paradise think Target Corporation stock is a good long-term investment.
    If you are looking for stocks with good returns, Target Corporation can be a profitable investment option. TGT is quoted at $126.89 today (2019-11-27).
    Based on historical data, but more on our analysis,  investors may expect an increase in TGT stock price after five years it can easily reach  $207 with revenue of more than 60%. If you invest $10.000 in this stock today after five years your investment could be over $16.000. The analysts’ recommendation is a strong BUY for this stock. This year Target is sixth-best performing stock in the S&P 500 index.

    About Target Corporation

    “Expect more. Pay, less.” This is the company’s motto from the early days. Target Corporation is founded by George D. Dayton, a New York businessman who’s first interest was the banking and real estate. He started this business on Nicollet Avenue, Minneapolis by opening the Dayton Dry Goods Company, today is known as Target Corporation. Dayton was head of the company until he died in 1938. Later, his son and grandsons developed the company into a national retailer.

    The first Target store started on May 1, 1962. It was a branch of the  Dayton’s department store offering “a new kind of mass-market discount store that caters to value-oriented shoppers seeking a higher-quality experience.”

    Its main rival is Walmart with prices hard to beat, and instead of that Target appeared as “cheap chic” by recruiting well-known designers like Michael Graves, Tracy Reese, or Lilly Pulitzer. This great tactic has made Target retail with richer customers than Walmart’s. Honestly, even the wealthiest Americans like to purchase at Target. Even the people with a net worth above $5 million are shopping there.

     

  • Builders FirstSource Inc. Is Good Long-Term Investment

    Builders FirstSource Inc. Is Good Long-Term Investment

    Builders FirstSource Inc. Is Good Long-Term Investment
    Builders FirstSource Inc is a good long-term investment with the possibility to produce almost 30% of revenue

    By Guy Avtalyon

    Builders FirstSource Inc BLDR stock is, according to analysts, rated as a buy. In November it was upgraded from a hold rating.

    This third-quarter earnings season, many companies reported better earnings per share and beat the experts’ estimations and expectations. There were a lot of outperformed stocks and investors are interested to add them in their portfolios because they want strong returns. But which one or few to choose? The market noise is enormous and it so hard for individual investors to make such a decision.

    Builders FirstSource Inc.

    Builders FirstSource (BLDR) is currently recommended as a buy. This stock is trading with a P/E ratio of 12.74. Meaning, at current prices, you have to pay $12.74 for every $1 in trailing yearly profits. Over the past 52 weeks, BLDR’s P/E ratio has been as high 25.65 and low 10.15. But value investors use the P/S ratio as a metric also. You can find the P/S ratio when divide the stock price by sales.

    On the last day of October Builders FirstSource issued its Q3 earnings report.

    Builders FirstSource’s quarterly earnings were $0.72 per share, meaning it beat experts’ expectations. The earnings per share were $0,67 for the same quarter last year.

    So, we can easily see earnings of 20%. Surprised? For the previous quarter,  it was supposed that this company would report earnings of $0.48 per share. But it delivered earnings of $0.63, showing an increase of 31.25%. For the last 12 months or 4 quarters, Builders FirstSource has exceeded consensus EPS estimates 4 times.

    The company posted revenues of $1.98 billion for the third quarter. This compares to year-ago revenues of $2.12 billion. The company has beaten consensus revenue estimates two times for the last four quarters.

    “Our strong third-quarter growth in sales volume and margins combined with our focus on working capital management generated another quarter of strong cash flow.  We were also pleased to deploy capital on an accretive acquisition, while at the same time, further improving our ratio of net financial debt to Adjusted EBITDA to 2.5 times,” said CFO Peter Jackson.

    BLDR stock is currently trading at $25,36.

    What’s next for the Builders FirstSource stock?

    The tricky question indeed. The price made a slight decline of 0,02% yesterday. You can use one simple measure: the company’s earnings outlook. You have to examine the current earnings expectations given by the experts but most importantly you have to check how their predictions have changed.

    The stock is bullish and Traders-Paradise opinion is the price can go up from $25.50 to $27 over the next 12 months. So, we can say it is profitable to invest in Builders FirstSource stock since the long-term earning potential is about 7.00% in the same period.

    The company’s ABOUT

    The company is a supplier and manufacturer of building materials, components, and construction services. 

    Builders FirstSource provides an integrated solution to its customers offering manufacturing, supply, and installation of building products such as windows, doors, and millwork lines.

    Its products are the factory-built roof and floor trusses, wall panels and stairs, vinyl windows, millwork and trim, and engineered wood designed, cut, and constructed. It constructs interior and exterior doors. 

    The company is headquartered in Dallas, Texas.

    Should you buy the Builders FirstSource stock?

    Traders-Paradise predicts a future increase in values of Builders FirstSource, Inc (BLDR) stock. If you want to hold stock with good return, Builders FirstSource, Inc might be a good option for you. Builders FirstSource, Inc quote is $25.36 at 2019/11/20. Based on previous performances this stock may be worth up to $32 with revenue of almost 28% after a five years period. If you invest $10.000 today in this company, after 5 years, it is possible to have about $12.800.

     

  • AVEO Pharmaceuticals Stock Increases The Price On Good News

    AVEO Pharmaceuticals Stock Increases The Price On Good News

    AVEO Pharmaceuticals.Stock

    Measured over the past 5 years, AVEO shows strong growth in revenue: 10.25% on average per year.
    AVEO is stock with a buy signal right now.

    By Guy Avtalyon

    AVEO Oncology (NASDAQ: AVEO) today announced the presentation of updated data from the Phase 3 TIVO-3 trial. Previously, the data were displayed on Saturday, November 16, 2019. It was at the 18th International Kidney Cancer Symposium in Miami. In verbal presentation named “TIVO-3: A Phase 3 Study to Compare Tivozanib to Sorafenib in Subjects with Refractory Advanced Renal Cell Carcinoma (RCC) Overall Survival 2-Year Update” by Sumanta Kumar Pal, M.D., Associate Clinical Professor, Department of Medical Oncology and Therapeutics Research, and Co-director, Kidney Cancer Program at City of Hope Comprehensive Cancer Center. 

    And the market reacted immediately. Traders-Paradise got the info that stock price is rising and here is the confirmation. Take a look at the chart below with updated data.

     

     

    About AVEO Pharmaceuticals, Inc.

    AVEO Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on the development of treatments targeting cancer.

    In August 2017, AVEO and its partner, EUSA Pharma, got approval from the EU Commission for its VEGF tyrosine kinase inhibitor, Fotivda (tivozanib) for the first-line treatment of advanced renal cell carcinoma RCC. The drug is available in Germany, Spain, Norway, Iceland, New Zealand, Austria, and the United Kingdom. AVEO got the exclusive rights to develop and commercialize tivozanib across all countries outside Asia and the Middle East under a license from Kyowa Hakko Kirin in 2006.

    AVEO Pharmaceuticals, Inc. reported earnings of 10 cents per share in the third quarter of 2019 and bounced from the loss of 18 cents from last year.

    Several days ago, on November 12, the company reported revenues of $25.7 million which is an increase of $2.5 million year-to-year. This new revenue beat all experts’ expectations. That influenced the stock price and it jumped a short after report for 8,8%. But that increase came after the stock dropped almost 65% this year while the whole industry marked an increase of 1,2%.

    Why invest in AVEO?

    This increase in stock price didn’t last for a long, 3 days later. November 15, the price dropped from $0.64 to $0.63 and decreased over 3 days in a row. The stock price varied 4.56% from a day low at $0.63 to a day high of $0.66. The good news is that the trading volume fell also because the volume has to follow the stock price. On the last trading day, the volume lowered by 2.34 million shares.
    And the price is rising at a high speed, more and more. At the moment of writing this post, it rose to almost 5%. Watch this stock. It is possible to see $10 next year.

     

  • Designer Brands A Value Stock To Watch

    Designer Brands A Value Stock To Watch

    Designer Brands A Value Stock To Watch
    Designer Brands Inc. is a US-based company, belongs to the Services sector and Apparel Stores industry. It has a market capitalization of $1.28B. 

    By Guy Avtalyon

    Designer Brands became the new name for DSW Inc.from May this year. At that time they announced they will add more other designers’ shoes and accessories. The company began trading under a new ticker, DBI, on the New York Stock Exchange on April 2.

    Let’s take a look at its potential as an investment. Actually, we’ll analyze its Return On Capital Employed (ROCE), because that will give us a sense of the quality of the business.

    ROCE will show the ‘return’ a company generates from its capital. When you see a company with higher ROCE it is a sign that you are dealing with a business with better quality.

    Here is the formula:

    Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets – Current Liabilities)

    For Designer Brands based on data for the first eight months this year, it is calculated

    0.084 = $160m ÷ ($2.6b – US$649m) or 8,4%

    Is it good or bad for Designers Brands?

    ROCE is helpful to see relations between related companies in the same industry. If we compare its ROCE, for example, with returns on bonds, we can see that this result wasn’t excellent. Designer Brands’s ROCE was average. And investors may find better opportunities in some other investment, right?

    ROCE of 8,4% is almost double less than what the company had 3 years ago when it was 15%. What does it mean? Well, several reasons can be in the play but it is obvious that the company has some problems.

    When you employ ROCE as a metric one thing you have to keep in your mind. It is a helpful tool, but it is not without disadvantages. You have to be cautious when examining the ROCE of different companies because there is no two or more companies that are precisely similar.

    ROCE isn’t necessarily a good metric due to the nature of the business. This kind of business usually has several sales peeks over the year but also the lower sales-rate periods. After the announcement of changing the name, Designer Brands’ revenue is constantly increasing.

    But what we can see is the Designer Brands has total liabilities of $649m and total assets of US$2.6b. So, its liabilities are approximately 25% of its assets which is a reasonable level and has a modest effect on ROCE.

    Designer Brands (DBI) is possible a good long-term investment. 

    The current price might go up to $20 in the next three months with a possible profit of up to 70% in 2 years.

    This stock has a strong buy signal since the short-term moving average is above the long-term moving average. It looks that further gains are very possible. But this stock is a risky one. It can move 3.40% between the high and low prices over one day as the historical data shows but last week’s average daily volatility was 3,37% which is medium. 

    If you are trading this stock maybe you should consider setting the stop-loss limit at -5,60%. It looks that this stock is currently well priced, it isn’t oversold and not overbought but the stock may be undervalued. That gives the space to raise more.

    Designer Brands (DBI) is a stock many investors are following right now. The stock forward P/E ratio is 7.76. Its industry’s average forward P/E is 10.72. Over the past 12 months, the highest forward P/E ratio was15.30 and the lowest was 6.84, which lead us to a median of 11.14.

    The price has been changed in four past weeks for 5.13% and for the last three months 18.80%. Considering the possibilities of its earnings, DBI stands out as one of the market’s hottest value stocks right now.

    What is Designer Brands?

    Designer Brands is one of the largest designers, producers, and retailers of footwear and accessories in the USA.

    Under the name, DSW (Designer Shoe Warehouse) the first store opened in 1991 in Dublin, Ohio. Today, DSW holds more than 500 stores in 44 states. Also, there is the Affiliated Business Group with almost 290 leased units for retailers, such as Stein Mart.

    The company also operates in Canada, in collaboration with The Shoe Company and Shoe Warehouse trough 150 locations. 

    In 2018, Designer Brands acquired Camuto Group, best known for the Vince Camuto® brand and the Jessica Simpson® and Lucky Brand®. This partnership provides Designer Brands to be one of the largest footwear companies in North America. It opened global capabilities in product design, development, and production. The company seems to be moving to a long-term strategy for growth and relevance with customers.

    Since 2005, the company is traded on the NYSE under the ticker symbol DBI.

     

  • Crocs Clogs Of Two Digits

    Crocs Clogs Of Two Digits

    Crocs Clogs Of Two Digits
    Crocs have sold more than 300 million pairs of shoes in more than 90 countries.
    Crocs is traded on the NASDAQ stock market under the ticker symbol CROX. Market Cap:  $2.44 B Current Price: $35.51

    Crocs reported Q3 on October, 30. The company reported revenues of $313 million, which represents the new third-quarter record for Crocs or an increase of 20% – 21%. It also reported reducing revenues due to currencies of $3.0 million and reduced revenues of $4.0 million due to closing stores. But the wholesale revenues increased by 25.4%, e-commerce sales rose 28.2%, and retail comparable store sales increased by 12.5%. Gross margin was 52.4%, in the same period last year it was 53.3%. Adjusted gross margin increased 30 basis points compared to last year’s third quarter. 

    Crocs had, according to the Q3 report, adjusted earnings per share of 57 cents. The experts’ estimation was 40 cents. The company’s shares were up more than 10% to nearly $37 after reporting. The current price is $35.51. CEO Andrew Rees said, “Our Americas business delivered exceptional growth, driven in part by another highly successful back-to-school season.”
    The great results produced a tendency for Crocs to boost its full-year guidance to 11%–12% revenue growth over 2018.

     

    “The Crocs brand momentum continues to gain pace, and for 2020 we anticipate revenue growth over 2019 of 12% to 14%,” said Rees.

    Crocs have closed more than 150 stores over the past several years. The competition was very strong. It has also focused its works on its Classic clog, profiting from the shift toward more casual and comfortable footwear. 

    Is Crocs a good investment?

    The investors should be enthusiastic about the Crocs (NASDAQ: CROX).
    Crocs is in the center of a strong increasing trend in the short term. The stock is assumed to increase 54.16% in the next 3 months and, so the price to climb between $52.32 and $62.85, expect experts. Moreover, they are seeing only positive signals for this company and strong buy signals from the short and long-term moving averages.
    A general buy signal is supported by the relationship of those two, the short-term average is above the long-term average.

    Where the problem may arise?

    The support level is between $35.42 and $32.45. If the price falls under these levels it will be a sell signal. For now, it is a strong buy signal and an indication of additional gains. The consideration may occur because the volume fell on November, 12 notwithstanding growing prices. This shows a divergence between volume and price and it may be an unexpected warning. 

    But some experts see a great potential of holding this stock in the long run. Their estimations show a possible fantastic 152% profit in 18 months. The investment analysts think the Crocs stock is good to buy. 

    Important info about Crocs

    Crocs, Inc. is a worldwide recognized as a leading producer of casual footwear with a broad portfolio of all-season colorful pairs of shoes. Crocs were first exposed at the 2002 Fort Lauderdale Boat Show.

    Famous clogs were originally developed as boat shoes produced by a Canadian Company, Foam Creations, Inc. The new shoes were molded into the shape of a human foot. Just a few years later they have become practical footwear in households and professions. The ugly trend overflowed the world. You cannot love Crocs because of its aesthetics. These ugly clogs made a trap for the brand. The producer claimed that only one pair will last a lifetime. The fashion industry surviving thanks to many and frequent shifts and this kind of thinking was so far from the industry. But that has never slowed Crocs down. The slippers wipe-clean and non-slip build sent them straight to kitchens, hospitals, everywhere the workers have to stay on their feet for a long time. 

    It went public in 2006

    The company had already adopted Crocs, Inc. In its presentation to investors, the company announced plans that requested for new footwear models, developed distribution in the US and over the world. 

    As investors’ interest in Crocs expanded, the company was able to increase its asking price and the number of shares on the market. Firstly, the plan was to sell 9.9 million shares at $13 to $15 per share. Crocs managed to add a bit more than a million shares and hit its asking price to the $19 to $20 range. Investors liked the company since the Crocs had extraordinary growth and a product that had a global appeal.

    Today nothing has changed. Crocs is one of the most popular producers of slippers. But that isn’t the only product they have: clogs, boots, other kinds of footwear, but with a common characteristic: comfortable, long-last, colorful and funny.
    The stock should be watched closely, it can produce a great profit.

     

  • Civeo Corporation Could Be Good Turnaround Stock

    Civeo Corporation Could Be Good Turnaround Stock

    Civeo Corporation Could Be Good Turnaround Stock
    Civeo Corporation is a spin-off the Oil States International.
    It is a US accommodation service and multinational corporation. It is a spin-off of Oil States International and a public company listed on the NYSE

    by Gorica Gligorijevic

    Civeo Corporation is publicly traded on NYSE under the ticker name CVEO. According to the current price, it may never be so cheap. What we think is that this stock could easily be a great opportunity for investing. How does it come? Well, when the stock is cheap as this one is just a small sign of good news can send them flying.

    What we are talking about is the Civeo Corporation stock is turnaround stock. It had happened before, this particular stock made 115% profit in 1 month. This stock is ready to give some of the highest returns. How do we know that? Well, as we said just a small sign appeared recently. Investor Carl Icahn bought a 9.9% stake. That is a sign of a turnaround. The most interesting thing with this stock is that you will receive the 4.7% dividend while waiting for a turnaround.

    If you buy this stock now it is possible to double its value very soon. This stock can perform very well in 2020 as being an incredible buy. 

    Market Cap $162.547M
    Current price $0.9587

     

    Why invest in Civeo Corporation stock?

    Turnaround stock investing is a real source for investors. Hence, when you notice that some stock has a great probability of return within a year.

    Civeo ( CVEO) reported third-quarter revenues of $148.2 million, a net income of $4.5 million, and an operating cash flow of $23.6 million.

    Civeo Corporation delivered a third-quarter adjusted EBITDA of $36.2 million. It is up 62% compared to the previous year, and also, there is a free cash flow of $20.3 million Also, the reduced leverage ratio from 4.26x to 3.52x on September 30, this year.

    The company completed the acquisition of Action Industrial Catering which provides the company’s presence in the Integrated Services and Western Australian markets. Moreover, for the fourth quarter of 2019, Civeo awaits adjusted EBITDA $19.5 million to $23.5 million. For the full of this year, Civeo Corporation is expanding adjusted EBITDA guidance in the range of $98.0 million to $102.0 million. Civeo is reducing its 2019 capital expenditure guidance to a span of $33 million to $37 million.

    “We are encouraged by the Company’s achievements this quarter and we will continue to focus on operational execution, revenue diversification, free cash flow generation, deleveraging our balance sheet and winning new work as opportunities present themselves,” said Bradley J. Dodson, Civeo’s President, and Chief Executive Officer.

    Civeo Corporation company

    Civeo Corporation is the foremost provider of hospitality services.  But also has notable market positions in the oil operations in Canadian and the Australian. Civeo gives full solutions for accommodations of workers with long term and temporary lodging and gives food services, full housekeeping, power generation, communications systems, and logistics services. Currently, Civeo Corporation operates a total of 30 lodges in Canada, Australia, and the U.S., with approximately 31,000 rooms.

    Why invest in turnaround stocks?

    First of all, they may never be cheap again. By investing in turnaround stocks you may score double or triple-digit gains. How? The beaten-down stocks with real value will survive and provide a profit despite the overall market because they are driven by key developments in the company. And, the most important, turnaround stocks can run independently of the markets.

    The turnaround stocks may be hidden for the majority of investors. Hence, you must have a focus on several key criteria. The company must have a stable focus on businesses and be able to recognize and drop all profitless ventures. Such a company makes changes in management with successful turnarounds. 

    In the past, such a company completed a turnaround plan that gave clear, real direction to employees. Also very important to be noticed, the company must have several great shareholders who will support the turnaround attempt. The company has to be a trustworthy brand. All of these are guarantees that stock will have a great turnaround. It’s up to us to recognize the potential and buy on a bargain.

    When you notice all these indicators, it means you have got the opportunity to buy a great turnaround stock. It is time to put some of your money into stocks that give excellent value and powerful management. Yes, they are still beaten down but is it fair? This particular stock is ready for a big return.

     

  • Brookfield Renewable Partners – High Yielding Stock

    Brookfield Renewable Partners – High Yielding Stock

    Brookfield Renewable Partners - High Yielding Stock

    Brookfield Renewable Partners trades on the Toronto Stock Exchange under the ticker symbol BEP.UN and on the New York Stock Exchange under the ticker symbol BEP.

    On November, 11. Brookfield Renewable Partners, a Canadian company, reported financial results for the three and nine months ended September 30, 2019. 

    The company has been doing great work last year to sustain its renewable energy portfolio and its balance sheet. The work showed great results over the third quarter. Brookfield Renewable Partners presented important cash flow growth. Moreover, the company plans to keep that success and to continue growing its 4.6%-yielding dividend.

    The company proceeded to execute on strategic priorities in the third quarter. There were many new investments, operations, and creating liquidity to reinforce its strong balance sheet.

    The stock is strongly bullish.
    Market Cap): $13.42 B
    Current price: $43.485

    Brookfield Renewable Partners - High Yielding Stock

     

    Sachin Shah, CEO of Brookfield Renewable said:

    “We are also pleased to announce our intention to create a Canadian corporation with publicly-traded shares that we expect will be economically-equivalent to the units of the partnership. This should position us well to continue attracting new investors to our globally-diversified renewable power portfolio.”

    Brookfield Renewable summarized Funds from operations (FFO) growth of 27% which is in currency $133 million or $0.43 per unit. It is for the last three months, until September 30, 2019.
    The net loss for the same period was $53 million or $0.17 per unit. These results were backed by recent acquisitions and the execution of its operating initiatives.

    The company’s portfolio is growing

    This Canadian company invested $100 million BEP equity into TerraForm Power and there was the acquisition of a 200-megawatt wind farm in China. Also, it sold two mature European wind portfolios for $74 million net to BEP,  from selling five of its six assets in South Africa, BEP gains $42 million of net profit. That selling of, returned nearly two times its capital invested.

    Brookfield Renewable Partners completed a C$600 million green bond issuance. That is the largest corporate level green bond ever issued in Canada. This transaction provides the company to increase the average duration of the corporate debt by 5 years to 10 years and to maintain a strong total available liquidity of $2.5 billion.

    Canadian Corporation

    The company announced an intention to form a Canadian corporation “in order to provide investors with greater flexibility in how they invest in Brookfield Renewable’s globally diversified, multi-technology renewable power portfolio” as they said in a statement. 

    The new entity will be publicly listed on the same exchanges as BEP. The quite interesting idea will give investors the possibility to invest in Brookfield Renewable Partners through a partnership or Canadian corporation. That could increase demand and improved liquidity for the company.

    Moreover, Brookfield Renewable Partners plans to distribute on a tax-free basis to the majority of unitholders, class A shares of the new corporation, Brookfield Renewable Corporation (BEPC). This will be an adjustment for the number of shares outstanding, without changing the aggregate cash flows or net asset value 

    The class A shares will be convertible for one BEP share. 

     

    The success of Brookfield Renewable Partners operations

    Its hydroelectric operations increased its cash flow by 20%. Although the company produced less electricity in the U.S. Northeast and Canada due to climate issues, BEP balanced that problem by making better results in its operations in South American and boosted the profitability of its businesses in Brazil and Colombia.
    Its wind business grew its cash flow by 24%. The benefits came from the acquisition of 210 megawatts of wind capacity in India and a 51 MW wind farm in Ireland. At the same time, its investment in TerraForm Power proceeded to pay dividends.
    Brookfield’s solar, storage, and other sections were flat for many years. But this year its solar business grew 16% thanks to growth at TerraForm.
    On the other side, earnings from storage were down 45.5%. That is the result of a 33% drop in actual production over the period.

    Bottom line

    Brookfield Renewable Partners’ third-quarter results reveal that its strategic plan manages to pay dividends. Hence, it is reasonable to expect that the company will be successful in the future.
    Its aim is to increase its cash flow at a more than 10% annual rate in the next 4 years. So, it will be easy for them to increase their high-yielding payout to 9% per year. So, what do you think, is this a good choice for investors willing to invest in renewable energy? For us, it looks like a good pick.

     

  • Qorvo Is Ready to Trade Higher

    Qorvo Is Ready to Trade Higher

    Qorvo Is Ready to Trade Higher
    Qorvo shares rose 20% last week.
    Its current-year earnings increasing almost 10% over the last two months

    By Guy Avtalyon

    Qorvo (QRVO) shares had been trading higher last week. Have you ever been thinking about owning a tech company’s stock? No? Well, it’s time to think about it. Avoid some regrets later. The people that didn’t recognize the potential of holding stocks of Apple or Microsoft are regretting now. 5G profit is unquestionable now. 

    5G stocks are in focus now. Technology has great potential and tech companies are always a good choice. 5G networks easily can be a sign of the opening of a new golden era for this technology.

    Investors who are able to recognize the potential in early-stage could profit a great. One of them could be QRVO.

    What is Qorvo

    Qorvo Inc. develops, produces, and sells scalable and dynamic radio-frequency modules for mobile, infrastructure, and defense applications. It is a wireless semiconductor industry and high tech. Qorvo designs amplifiers, integrated modules, optical components, oscillators, filters, duplexers, frequency converters, switches, and other facilities for apps that run wireless and broadband communications.

    Qorvo, Inc. is a provider of technologies and RF solutions and markets its products to the United States and international original equipment manufacturers and original design manufacturers. Its sections cover Mobile Products and Infrastructure and Defense Products. It works design, sales and manufacturing departments located in Asia, Europe, and North America.

    Qorvo stock

    The company trades on NASDAQ and its headquarters are in Greensboro, North Carolina. Its products end up on other products almost everywhere. The wireless industry is still expanding and it will be part of our lives for a long time.

    The 5G stocks are better than ever and last week’s earnings from Qorvo showed it is a great beginning. Its current-year earnings growing almost 10% over the last two months.

    GAAP earnings weren’t quite great but they are still notable strong. In the Q2 earnings report, the company reported GAAP earnings of $0.70 per share. That is almost three times the $0.25 Qorvo earned last year. But, also, the company reported sales to drop 9%.

    The news looks like it’s going to get better as the year advances. In its financial guidance for Q3, the company’s management stated the expectation that sales should rise regularly from $840 million to $860 million. It will be much over the almost flat revenues of $758 million, which is the Wall Street prediction.

    Earnings should be about $1.67 per share which is a great discrepancy with Wall Street is looking for $1.35.

    Does Qorvo’s stock has potential? 

    Mobile demand is healthy and increasing which is good news for this company. Investors who are buying this stock are truly right. If we have info about the developments of 5G in our mind and how Qorvo plans its role among other companies, it sounds like a good choice. As we had the opportunity to see, Qorvo shares climbed 20% last week and it was aligned with its progress over the past two months.

    In the third quarter of fiscal 2020, the company expects a non-GAAP gross margin of nearly 48%, and non-GAAP diluted earnings per share of $1.67 is stated in its guidance for the third quarter. 

    For mobile, the company expects December quarter sales to grow as 5G handsets launch with its integrated solutions. There are also other contracts, for example, sales will increase on higher-defense business volumes. Also, increasing 5G infrastructure customer demand promises good days for Qorvo.

  • Alibaba Stock is Attractive for The Long Term Investment

    Alibaba Stock is Attractive for The Long Term Investment

    Alibaba stock is attractive for the long term investment
    Analysts have called e-tailer Alibaba Group Holding Ltd “Amazon of China” and for good reason.
    Alibaba is one of the few e-commerce companies in the world that can come close to Amazon’s size and growth potential.

    By Guy Avtalyon

    Update 08/11/2019: Alibaba stock (NYSE:BABA) broke out the  $185 level and scored the high. Yesterday it was traded at $186.66.

     

    Alibaba stock was traded on Tuesday, November 5 at $182,00 which means that it needs to rally less than 2% to reach $185, the new maximum this year. The best Chinese stocks need to clear one crucial level to be able for a breakout. It is $185 level, a very important level that might give it the strength to move up and hit the $210 the highest price ever got in 2018.

    Over the last almost a year and a half we can notice a range of higher lows, so we can easily say it is positive. Yes, but we can also see a set of lower highs. If Alibaba move over $185 that will be a new high and good level for increasing to the $210, historically highest high. 

    It will be interesting to watch this stock over this month.

    Is Alibaba able to do so?

     

    Alibaba reported Q3 earnings on November 1. All expectations are beating because the company reported an incredible increase in sales. The online-retail business rose an awesome 40% year over year in the September quarter. 

    But that’s not all. The real rise will come on China’s Singles Day on November 11. That is a shopping storm. The original aim of this holiday was dedicated to single people to celebrate not being in relationships. But it turned into something like Black Friday but more huge, more intensive, a real shopping storm. Today it is an indicator of buyers’ sentiment and sales growth. Can you guess who played the big? Maybe the biggest role in turning this holiday to insane shopping of everything has Alibaba.

    Singles Day began as a weird celebration for single people in China back in the 1990s. Just write November 11as numbers only. It is 11. 11, right? Singles Day started as a kind of anti-Valentine’s Day when students at Nanjing University began celebrating the fact they are single.

    After 10 years Alibaba literally adopted that day and turned it in a day when everyone, no matter single or not, orders themselves a gift.
    Online shoppers in China made $30.8 billion in sales last year on that day. This spending orgy has surpassed Cyber Monday in the US for online shopping made on a single day.
    Since last year’s score was 27% higher than a year ago, what can we expect this year? We are afraid that any forecasts will be beaten. Have in mind that Alibaba made a billion dollars in sales in the first 2 minutes shopping (actually, it needed only 90 secs). A real retail phenomenon! And Alibaba is a recorder.

    Alibaba.com (NYSE:BABA) is the biggest e-commerce and cloud player in China.

    In its Q2 earnings report, we can see its revenue increased by 40% annually to $16.65 billion v.s. estimated $180 million.

    Company’s generally accepted accounting principles or GAAP net income, include a big profit from its stake in the fintech company Ant Financial, which rose 288% to R$9.9 billion, which is $3.85 per share. If we exclude that profit and some others, the net income increased 40% $4.58 billion, or $1.83 per share. Estimations were beaten again.

    After the Q2 earnings report the stock price jumped but for a short probably because of investors’ worries toward the U.S.-China trade war. Also, the economic slowdown in China had an influence.

    Should you enter a position in Alibaba?

    Alibaba’s focus commerce revenue grew 40% annually, its operating profit rose 32%, preserving its position as Alibaba’s entirely profitable venture.
    There are some concerns about the Chinese economy’s slowdown.

    Should you invest in Alibaba stock?

    Revenue growth of 40% is an amazing amount for a company of virtually any volume. But keep in mind that Alibaba is the world’s seventh-most valuable public company. So, that percentage is a miracle. 

    The number of their active consumers increased by 19 million last quarter and now they have 693 million users. They have 785 million mobile monthly active users, which is 30 million more over three months. Alibaba aims to have more than 1 billion buyers by 2024, and it looks like it will reach that goal.

    How to invest in Alibaba

    The best way to invest in Alibaba wisely is by having a long horizon. The company has a fantastic position, its strength in e-commerce is supported by its huge data insights on Chinese buyers, also its increase in market share in the cloud computing industry.

    Also, there’s the Chinese growing middle class with increased buying power. The extra income has proven to be important to Alibaba’s continued high growth. Also, there is the Chinese government as a safety net. China supports its favorite companies on the international stage, that’s a fact. Protectionism from the Chinese government works fully in favor of BABA stock, backing it to enter the “buy” choice.

    The drawbacks of Alibaba stock

    The founder, Jack Ma,  stepped down as chairman of the board in September this year. That is a signal the risk is here. What lies behind the company’s founder and former CEO leaving?  The other problem is an extremely high bar the Alibaba set for itself.
    The risk is that this growth will decelerate. But at what speed? The analysts predicted speed or it will be due to a quick sale by growth investors?

    Will Alibaba’s success continue?

    The company has one of the most advantageous competitive aspects.

    Alibaba’s large market share in plenty of high-growth, scalable, tech-based fields makes it dominate in the coming years. But something must be taken into consideration. China has a great impact on the company, honestly too great. China’s government’s influence is a risk by itself. The additional risks may come due to the trade war. Just compare Alibaba”s valuation to results they have in the last few quarters and you will conclude that investors are paying attention to the trade war.

    Alibaba stock trades at 32 times earnings. Is it in line with revenue growth of 40% and earnings per share increased by 36 %? It’s low multiple. Maybe that’s not a wonder, with shares trading lower than they did 18 months ago. Buying Alibaba stock is a calculated risk and one that could pay very soon if the trade war ends.